Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections (Q34308017)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections |
scientific article |
Statements
1 reference
Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections (English)
1 reference
Robert A Bonomo
1 reference
Eszter Ostorhazi
1 reference
Ferenc Rozgonyi
1 reference
Andras Sztodola
1 reference
Ferenc Harmos
1 reference
Ilona Kovalszky
1 reference
Dora Szabo
1 reference
Daniel Knappe
1 reference
Ralf Hoffmann
1 reference
Marco Cassone
1 reference
Laszlo Otvos
1 reference
1 September 2010
1 reference
1 reference
65
1 reference
11
1 reference
2416-2422
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference